This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Taffet Gold H, Hall MJ, Blinder V, Schackman BR.Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer. Cancer 115: 3858-3867, No. 17, 1 Sep 2009
Rights and permissions
About this article
Cite this article
Pharmacogenetic testing before irinotecan likely to pay off?. Pharmacoecon. Outcomes News 588, 6 (2009). https://doi.org/10.2165/00151234-200905880-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905880-00010